WAVE.V -- Bottoming Out Undervalued Pharma/COVID-19 PlayThe most attractive part of WAVE.V is share structure: 54M total float with 41M shares held by insiders / escrowed, leaving about 13M shares free trading. The company owns a portfolio of generic oncology drugs from which it generates over $300K of quarterly revenue. $1M in cash on hand. Based on las
−0.040 CAD
−2.22 M CAD
412.09 K CAD
13.55 M
About WAVERLEY PHARMA INC
Sector
CEO
Larry Thiessen
Headquarters
Winnipeg
Website
Founded
2014
FIGI
BBG00J37TKF7
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
WAVE.V -- Pharma company offering oncology/COVID-19 drugsBig jump in this little known Canadian pharma's stock price this morning on news of market authorization of their drugs in multiple European countries. Tiny float makes for big moves up and down. Good speculative buy on pullback in the .20s, IMO.
Waverley Pharma Announces Grant of Market Authorizat
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of WAVE is 0.015 CAD — it has increased by 50.00% in the past 24 hours. Watch WAVERLEY PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange WAVERLEY PHARMA INC stocks are traded under the ticker WAVE.
WAVE stock hasn't changed in a week, the last month showed zero change in price, over the last year WAVERLEY PHARMA INC has showed a −40.00% decrease.
WAVE reached its all-time high on Oct 30, 2017 with the price of 0.600 CAD, and its all-time low was 0.010 CAD and was reached on Aug 23, 2024. View more price dynamics on WAVE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
WAVE stock is 33.33% volatile and has beta coefficient of −1.79. Track WAVERLEY PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is WAVERLEY PHARMA INC there?
Today WAVERLEY PHARMA INC has the market capitalization of 810.00 K, it has increased by 20.00% over the last week.
Yes, you can track WAVERLEY PHARMA INC financials in yearly and quarterly reports right on TradingView.
WAVE net income for the last quarter is −344.83 K CAD, while the quarter before that showed −264.13 K CAD of net income which accounts for −30.56% change. Track more WAVERLEY PHARMA INC financial stats to get the full picture.
No, WAVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAVERLEY PHARMA INC EBITDA is −1.07 M CAD, and current EBITDA margin is −214.10%. See more stats in WAVERLEY PHARMA INC financial statements.
Like other stocks, WAVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAVERLEY PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So WAVERLEY PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating WAVERLEY PHARMA INC stock shows the sell signal. See more of WAVERLEY PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.